Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Spain's Almirall to buy U.S. dermatology portfolio from Allergan
In This Article:
Aug 3 (Reuters) - Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.
Almirall said it would pay $550 million in cash upfront and that there is a possibility of an earn-out of up to $100 million based on business performance.
(Reporting by Katarzyna Zajaczkowska in Gdynia; editing by Jason Neely)
Terms and Privacy Policy